TWS-119

SynDRA canonical compound SYN1966690 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	GSK3B \| JUN \| MYC
Mechanism of action	glycogen synthase kinase inhibitor

All known targets

GSK3B
JUN
MYC

Mechanisms of action (all sources)

glycogen synthase kinase inhibitor

Cross-references

Synonyms

TWS 119
TWS119
3-[[6-(3-Aminophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenol
GSK inhibitor XII
GSK-3beta Inhibitor XII, TWS119
Neurogenesis Inducer, TWS119
CHEMBL405759
3-(6-(3-aminophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenol
3-((6-(3-AMINOPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)OXY)PHENOL
3-{[6-(3-aminophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy}phenol
Phenol, 3-[[6-(3-aminophenyl)-1H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]-
K00245
MLS006011018
GTPL5980
SCHEMBL5559045
GSK-3BETA INHIB

Look up TWS-119 in the interactive SynDRA portal →